TokenPost·

Alnylam Leads Healthcare Q3 EPS Surprise Ranking With $14.01 Beat

Your call?

Edgewise Therapeutics posted a $7.14 surprise and GRAIL ranked third at $4.90. Alnylam’s quarterly revenue rose 17% to $1.46 billion.

Share

More news